Screening must be supplemented by broader public health approaches. Screen and treat strategies to prevent type 2 diabetes are doomed to failure, according to a large new systematic review and meta-analysis published in The BMJ. Instead, the authors said and outside experts agreed, any effort to combat the already enormous and still growing problem of type 2…
Prominent Cardiologists Decry Tepid Support For Empagliflozin By Endocrinologists
July 5, 2016 by 1 Comment
At the FDA advisory panel empagliflozin enjoyed strong support from the cardiologists and statisticians but not from the endocrinologists. An FDA advisory panel last week turned out to be a much more contentious and divided than many had expected. Based on the FDA’s own analysis of last year’s Empa-Reg Outcome trial I had predicted that the…
Statins And Diabetes: A Clearer Picture Emerges
September 9, 2014 by 1 Comment
In recent years, the medical community has become increasingly aware that taking statins can result in slightly higher glucose levels, and this can lead to a diagnosis of diabetes in a small but statistically significant number of people. But it has been unclear whether the diagnosis of diabetes in people taking statins also places them…
Glucose Measurements Don’t Improve Cardiovascular Risk Assessment
March 25, 2014 by Leave a Comment
Although blood glucose and glycated hemoglobin (HbA1c) play a central role in diabetes, the value of these measurements to assess cardiovascular risk has been unclear. Now, in a paper published in JAMA, members of the Emerging Risk Factors Collaboration analyze data from nearly 300,000 people without known diabetes or cardiovascular disease who were enrolled in…
Recent Comments